Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus

European Neurology

Volumn 61, Issue 3, 2009, Pages 143-148

  Baizabal Carvallo, José Fidel ^a,b   Delgadillo Márquez, German ^a   Estañol, Bruno ^a   García Ramos, Guillermo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Institiuto Nacional de Ciencias Médicas Y Nutricion   (Mexico)

Author keywords

Meningitides, outcomes; Septic and aseptic meningitis; Systemic lupus erythematosus, risk factors

Indexed keywords

STEROID;

ADULT; ARTICLE; ASEPTIC MENINGITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FEMALE; HUMAN; LISTERIA MONOCYTOGENES; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MYCOBACTERIUM TUBERCULOSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEPTIC MENINGITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENINGITIS; MENINGITIS, ASEPTIC; MENINGITIS, BACTERIAL; MENINGITIS, CRYPTOCOCCAL; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 57649135335     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000186504     Document Type: Article

References (31)

1. Cervera R, Khamashta MA, Font J, et al: Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999;78:167-175.
2. Petri M, Genovese M: Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 1992;19:1559-1565.
3. Noel V, Lortholary O, Casassus P, et al: Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001;60:1141-1144.
4. Mok CC, Lee KW, Ho CT, et al: A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000;39:399-406.
5. Iriya SM, Capelozzi VL, Calich I, et al: Causes of death in patients with systemic lupus erythematosus in Sao Paulo, Brazil: a study of 113 autopsies. Arch Intern Med 2001;161:1557-1561.
6. Kim WU, Min JK, Lee SH, et al: Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol 1999;17:539-545.
7. Jacobsen S, Petersen J, Ullman S, et al: Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol 1999;28:75-80.
8. Alarcón GS, McGwin G Jr, Bastian HM, et al: Systemic lupus erythematosus in three ethnic groups. VII. Predictors of early mortality in the LUMINA cohort. Arthritis Rheum 2001;45:191-202.
9. Hernández-Cruz B, Tapia N, Villa-Romero AR, et al: Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin Exp Rheumatol 2001;19:395-400.
10. Durand ML, Calderwood SB, Weber DJ, et al: Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med 1993;328:21-28.
11. Moris G, Garcia-Monco JC: The challenge of drug-induced aseptic meningitis. Arch Intern Med 1999;159:1185-1194.
12. Widener HL, Littman BL: Ibuprofen-induced meningitis in systemic lupus erythematosus. JAMA 1978;239:1062-1064.
13. Sands ML, Ryczak M, Brown RB: Recurrent aseptic meningitis followed by transverse myelitis as a presentation of systemic lupus erythematosus. J Rheumatol 1988;15:862-864.
14. Suzuki Y, Kitagawa Y, Matsuoka Y, Fukuda J, Mizushima Y: Severe cerebral and systemic necrotizing vasculitis developing during pregnancy in a case of systemic lupus erythematosus. J Rheumatol 1990;17:1408-1411.
15. Marin OS, Estanol BV: Cerebral vasculitis presenting as a meningoencephalitis. A case of systemic lupus erythematosus. Del Med J 1973;45:315-319.
16. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
17. ACR Ad hoc Committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640.
19. Gladman D, Ginzler E, Goldsmith C, et al: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-368.
20. Kraus A, Cabral AR, Sifuentes-Osornio J, Alarcon-Segovia D: Listeriosis in patients with connective tissue diseases. J Rheumatol 1994;21:635-638.
21. Victorio-Navarra ST, Dy EE, Arroyo CG, et al: Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 1996;26:628-634.
22. Hung JJ, Ou LS, Lee WI, Huang JL: Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 2005;32:40-43.
23. Mitchell SR, Nguyen PQ, Katz P: Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum 1990;20:174-184.
24. Wilson JG, Ratnoff WD, Schur PH, et al: Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum 1986;29:739-747.
25. Cunha BA: Infections in nonleukopenic compromised hosts (diabetes mellitus, SLE, steroids and asplenia) in critical care. Crit Care Clin 1998;14:264-282.
26. Bermas BL, Petri M, Gladman D, et al: T helper cell dysfunction in systemic lupus erythematosus (SLE). Relation to disease activity. J Clin Immunol 1994;14:169-177.
27. Pryor BD, Bologna SB, Kahl LE: Risk factors for serious infection during treatment with cyclophosphamide and high dose of corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996;39:1475-1482.
28. Jennekens FGI, Kater L: The central nervous system in systemic lupus erythematosus. 2. Pathogenic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002;41:619-630.
29. Hanly JG, Walsh NMG, Sangalang V: Brain pathology in systemic lupus erythematosus. J Rheumatol 1992;19:5:732-741.
30. Okada J, Hamana T, Kondo H: Anti-U1RNP antibody and aseptic meningitis in connective tissue diseases. Scand J Rheumatol 2003;32:247-252.
31. Dubos F, Moulin F, Gajdos V: Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 2006;149:72-76.